Collagen is the most abundant protein in the body and the main structural material in cartilage, so using it for joints has an intuitive logic: replace what wears down. Cetyl myristoleate isn't structural at all. That difference in purpose is the heart of the comparison.
A protein and a lipid
Collagen is a structural protein. In a joint, it's the scaffolding of cartilage — what gives the tissue its strength and elasticity. The idea behind supplementing it is to support the body's own cartilage structure.
Cetyl myristoleate is a lipid — an oil-family compound whose proposed role is lubrication and comfort, not scaffolding. One aims at the joint's structure; the other at how that joint feels and moves. (See the chemistry breakdown.)
Two collagens, actually
Worth knowing before you shop, because "collagen" on a label can mean two quite different things:
- Hydrolyzed collagen (collagen peptides) — collagen broken into small, absorbable fragments, taken in gram doses. The theory is that it supplies raw material and signals that may encourage cartilage-matrix synthesis.
- Undenatured type II collagen (UC-II) — taken in tiny amounts (around 40 mg) and working by an entirely different route: a process called oral tolerance, in which small doses are thought to calm the immune activity that contributes to joint wear.
They're not interchangeable, and they don't work the same way — a detail many product pages skip.
Give collagen its due
Collagen's research has been building, and some of it is encouraging. Undenatured type II collagen in particular has several randomized trials in knee osteoarthritis showing improvements in pain and function — with at least one study reporting it outperformed a glucosamine-and-chondroitin combination. Hydrolyzed collagen has supportive results too.
The honest caveats: many trials are relatively small, formulations vary widely, and a number are industry-funded, so reviewers consistently call for larger independent studies. Still, on balance collagen's human evidence base for joints is broader than cetyl myristoleate's — which we'll keep saying wherever it's true. CM's case rests on offering a different mechanism, not on out-citing collagen.
| Cetyl Myristoleate | Collagen | |
|---|---|---|
| What it is | Monounsaturated fatty acid ester (a lipid) | Structural protein (peptides or undenatured type II) |
| Targets | Lubrication & comfort — how the joint moves | Structure — the cartilage scaffolding itself |
| Forms | CM8® capsules / chews | Hydrolyzed peptides (grams); UC-II (~40 mg) |
| Human evidence | Smaller; joint-comfort focused | Broader; UC-II has several positive knee-OA RCTs (scale limited) |
| Status | Dietary supplement | Dietary supplement |
So… which one?
The pattern you've probably noticed by now holds here too: these aren't really rivals. Collagen works on the structural side; cetyl myristoleate works on the comfort-and-lubrication side. A joint is more than one problem, which is why thoughtfully built formulas often include both rather than betting on one.
Flexcin's human formula, in fact, combines CM8® cetyl myristoleate with collagen (along with glucosamine and MSM) for precisely that reason. Read how the lipid piece fits in for people and pets.